CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-18 | RING TIMOTHY M Director | Grant or award | +1,292 | 23,933 | ||
| 2022-05-18 | PFEIFFER GARY M Director | Grant or award | +1,292 | 24,982 | ||
| 2022-05-18 | MAIN TIMOTHY L Director | Grant or award | +1,292 | 22,243 | ||
| 2022-05-18 | Gregg Vicky B Director | Grant or award | +1,292 | 16,922 | ||
| 2022-05-18 | MORRISON DENISE M Director | Grant or award | +1,292 | 6,540 | ||
| 2022-05-18 | Lassiter Wright III Director | Grant or award | +1,292 | 4,633 | ||
| 2022-05-17 | PREVOZNIK MICHAEL E SVP & General Counsel | Exercise or conversion | +50,604 | $66.51 | $3.4M | 89,828 |
| 2022-05-17 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −50,604 | $139.97 | $7.1M | 39,224 |
| 2022-05-17 | PREVOZNIK MICHAEL E SVP & General Counsel | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −50,604 | $66.51 | $3.4M | 0 |
| 2022-04-18 | Gregg Vicky B Director | Other acquisition | +61 | $134.88 | $8K | 15,630 |
| 2022-04-01 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +306 | $135.45 | $41K | 11,991.02 |
| 2022-03-08 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −6,228 | $135.21 | $842K | 39,224 |
| 2022-03-08 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −7,032 | $135.21 | $951K | 67,733 |
| 2022-03-07 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award | +2,310 | $130.09 | $301K | 32,718 |
| 2022-03-07 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −835 | $130.09 | $109K | 31,883 |
| 2022-03-07 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award | +206 | $130.09 | $27K | 32,089 |
| 2022-03-07 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −79 | $130.09 | $10K | 32,011 |
| 2022-03-07 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Grant or award | +70,184 | $130.09 | $9.1M | 367,403 |
| 2022-03-07 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Shares withheld for taxes | −32,570 | $130.09 | $4.2M | 334,833 |
| 2022-03-07 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +11,544 | $130.09 | $1.5M | 50,768 |
Page 31 of 42 · 826 trades